Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 19/20 | 0.40 |
| ▸ | CCR5 | P51681 | 12/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3944847 | 1.00 | CCR2 (0.40) | CCR2CCR5KCNH2KDM4E | |
| SCHEMBL2347872 | 1.00 | CCR2 (0.40) | CCR2CCR5KCNH2KDM4E | |
| SCHEMBL3943951 | 1.00 | CCR2 (0.40) | CCR2CCR5KCNH2KDM4E | |
| SCHEMBL2347863 | 1.00 | CCR2 (0.40) | CCR2CCR5KCNH2KDM4E | |
| SCHEMBL3743758 | 0.81 | CCR2 (0.36) | CCR2CCR5KCNH2 | |
| SCHEMBL3743751 | 0.81 | CCR2 (0.36) | CCR2CCR5KCNH2 | |
| SCHEMBL13600779 | 0.81 | CASP3 (0.45) | — | |
| SCHEMBL3741481 | 0.80 | CCR2 (0.36) | CCR2CCR5KCNH2 | |
| SCHEMBL2786216 | 0.79 | CCR2 (0.52) | CCR2CCR5KCNH2 | |
| SCHEMBL2786223 | 0.79 | CCR2 (0.52) | CCR2CCR5KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2049519-A2 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Brystol-Myers Squibb Company (US) | 2009-04-22 | — | — | EP | disclosed |
| EP-2046779-A2 | MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY, CRYSTALLINE FORMS AND PROCESS | Bristol-Myers Squibb Company (US) | 2009-04-15 | — | — | EP | disclosed |
| WO-2008014360-A2 | MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY, CRYSTALLINE FORMS AND PROCESS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-01-31 | — | — | WO | disclosed |
| WO-2008014361-A2 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-01-31 | — | — | WO | disclosed |